论文部分内容阅读
作者等曾报道将左旋18-甲基炔诺酮(LN)和雌二醇(E_2)制成透皮双控释放避孕剂(TCD),每周贴1片,于周期第5天开始,连续3周,停药1周,以期发展为理想的避孕方法。
The authors have reported that transdermal controlled-release contraceptive (TCD) of L-18-norgestrel (LN) and estradiol (E 2) has been reported as 1 tablet per week starting on the 5th day of the cycle and continuous 3 weeks, withdrawal for 1 week, with a view to developing an ideal contraceptive method.